Coya Therapeutics Inc (COYA) Stock Price

4.77 ▲ +0.19 (+4.15%)
Open: 4.68 Vol: 0 Day's range: 4.68 - 4.81 Aug 07, 10:47 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
COYA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 4.76▼ 4.73▼ 4.64▲ 4.57▲ 4.59▲
MA10 4.74▼ 4.65▲ 4.61▲ 4.32▲ 4.84▼
MA20 4.66▲ 4.61▲ 4.59▲ 4.45▲ 4.62▲
MA50 4.60▲ 4.56▲ 4.34▲ 4.84▼ 5.15▼
MA100 4.58▲ 4.31▲ 4.34▲ 4.61▲ 5.72▼
MA200 4.53▲ 4.36▲ 4.84▼ 5.00▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.009▲ 0.016▲ 0.002▲ 0.059▲ 0.003▲
RSI 54.846▲ 59.410▲ 61.862▲ 52.675▲ 48.692▼
STOCH 77.671     81.395▲ 58.141     79.513     34.753    
WILL %R -42.308     -36.667     -33.846     -11.518▲ -64.119    
CCI 13.247     72.866     180.253▲ 138.717▲ -50.887    
Latest Filters Detected On COYA
RSI $COYA RSI(14) Crossed Above 50 Set Alert
MA $COYA Price Crossed Above MA(26) Set Alert
▲ GAP $COYA Open Gap Up %2 Set Alert
▲ BREAK $COYA Price Breaks 10 Days High Set Alert
CDL $COYA Shooting Star Candlestick Pattern Detected Set Alert
CDL $COYA Doji Candlestick Pattern Detected Set Alert
Coya Therapeutics Inc News
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Monday, June 15, 2026 05:00 AM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Monday, May 11, 2026 09:30 PM
Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company” ...
Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in ...
Thursday, April 09, 2026 05:00 AM
The study evaluated serum biomarkers of lipid peroxidation, systemic inflammation, and axonal integrity in 100 randomly selected patients with ALS and included 100 healthy controls to allow for a ...
COYA historical stock data
date open high low close volume
07/08/26 4.68 4.81 4.68 4.70 51,913
06/08/26 4.555 4.695 4.52 4.58 249,793
05/08/26 4.61 4.6714 4.485 4.55 99,696
04/08/26 4.45 4.65 4.43 4.57 145,677
03/08/26 4.24 4.46 4.13 4.43 116,954
31/07/26 4.08 4.22 3.995 4.19 179,952
30/07/26 3.94 4.12 3.92 4.08 151,354
29/07/26 4.00 4.15 3.855 3.87 144,314
28/07/26 4.26 4.29 3.985 4.00 203,218
27/07/26 4.33 4.405 4.24 4.265 81,170
Quote Details
52wk Low:3.71
52wk High:7.75
Vol:0
Avg Vol(3m):3.5M
1Y Chng:-27.69%
1M Chng:-14.55%
Add to Watch List
More Information
Index US Composite
Market Cap. 107.43M